Stay updated with breaking news from Immunotherapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proof of mechanism and safety has been established for the first-in-class bisialidase and Fc fusion protein E-602 in advanced solid tumors, supporting its continued investigation and viability of harnessing glycan-mediated immune regulation as a novel therapeutic approach in this population.
Inhaling menthol could stave off the devastating memory loss and mental decline associated with the most common form of dementia, Spanish researchers have reported.
Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens,
Researchers from Cima University of Navarra (Spain) have shown in animal models of Alzheimer's disease that inhaling menthol improves cognitive ability.
Jason J. Luke, MD, FACP, discusses initial results from the phase 1 GLIMMER-01 trial of E-602 in advanced solid tumors.